A citation-based method for searching scientific literature

Zsolt Baranyai, Fabio Carniato, Alessandro Nucera, Dávid Horváth, Lorenzo Tei, Carlos Platas-Iglesias, Mauro Botta. Chem Sci 2021
Times Cited: 7







List of co-cited articles
63 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Chemistry of MRI Contrast Agents: Current Challenges and New Frontiers.
Jessica Wahsner, Eric M Gale, Aurora Rodríguez-Rodríguez, Peter Caravan. Chem Rev 2019
431
100

Fe(deferasirox)2: An Iron(III)-Based Magnetic Resonance Imaging T1 Contrast Agent Endowed with Remarkable Molecular and Functional Characteristics.
Lorenzo Palagi, Enza Di Gregorio, Diana Costanzo, Rachele Stefania, Camilla Cavallotti, Martina Capozza, Silvio Aime, Eliana Gianolio. J Am Chem Soc 2021
7
85

Low-Molecular-Weight Iron Chelates May Be an Alternative to Gadolinium-based Contrast Agents for T1-weighted Contrast-enhanced MR Imaging.
Philipp Boehm-Sturm, Akvile Haeckel, Ralf Hauptmann, Susanne Mueller, Christiane K Kuhl, Eyk A Schellenberger. Radiology 2018
50
85

Molecular Magnetic Resonance Imaging Using a Redox-Active Iron Complex.
Huan Wang, Veronica Clavijo Jordan, Ian A Ramsay, Mozhdeh Sojoodi, Bryan C Fuchs, Kenneth K Tanabe, Peter Caravan, Eric M Gale. J Am Chem Soc 2019
49
71

Dinuclear Fe(III) Hydroxypropyl-Appended Macrocyclic Complexes as MRI Probes.
Didar Asik, Samira M Abozeid, Steven G Turowski, Joseph A Spernyak, Janet R Morrow. Inorg Chem 2021
10
57

Fe-HBED Analogs: A Promising Class of Iron-Chelate Contrast Agents for Magnetic Resonance Imaging.
Brian C Bales, Brian Grimmond, Bruce F Johnson, M Todd Luttrell, Dan E Meyer, Tatyana Polyanskaya, Michael J Rishel, Jeannette Roberts. Contrast Media Mol Imaging 2019
14
57

Iron(III)-tCDTA derivatives as MRI contrast agents: Increased T1 relaxivities at higher magnetic field strength and pH sensing.
Jing Xie, Akvile Haeckel, Ralf Hauptmann, Iweta Pryjomska Ray, Christian Limberg, Nora Kulak, Bernd Hamm, Eyk Schellenberger. Magn Reson Med 2021
9
57

Modulating the Properties of Fe(III) Macrocyclic MRI Contrast Agents by Appending Sulfonate or Hydroxyl Groups.
Didar Asik, Rachel Smolinski, Samira M Abozeid, Travis B Mitchell, Steven G Turowski, Joseph A Spernyak, Janet R Morrow. Molecules 2020
13
57

A Class of FeIII Macrocyclic Complexes with Alcohol Donor Groups as Effective T1 MRI Contrast Agents.
Eric M Snyder, Didar Asik, Samira M Abozeid, Ariel Burgio, Gage Bateman, Steven G Turowski, Joseph A Spernyak, Janet R Morrow. Angew Chem Int Ed Engl 2020
28
57

Gadolinium(III) Chelates as MRI Contrast Agents: Structure, Dynamics, and Applications.
P Caravan, J J Ellison, T J McMurry, R B Lauffer. Chem Rev 1999
57

Exploring Inner-Sphere Water Interactions of Fe(II) and Co(II) Complexes of 12-Membered Macrocycles To Develop CEST MRI Probes.
Christopher J Bond, Gregory E Sokolow, Matthew R Crawley, Patrick J Burns, Jordan M Cox, Ramasamy Mayilmurugan, Janet R Morrow. Inorg Chem 2019
13
42

Rational Ligand Design Enables pH Control over Aqueous Iron Magnetostructural Dynamics and Relaxometric Properties.
Huan Wang, Alison Wong, Luke C Lewis, Genevieve R Nemeth, Veronica Clavijo Jordan, Jeffrey W Bacon, Peter Caravan, Hannah S Shafaat, Eric M Gale. Inorg Chem 2020
6
50

Comparison of phosphonate, hydroxypropyl and carboxylate pendants in Fe(III) macrocyclic complexes as MRI contrast agents.
Elizabeth A Kras, Samira M Abozeid, Waldine Eduardo, Joseph A Spernyak, Janet R Morrow. J Inorg Biochem 2021
4
75

Applications for Transition-Metal Chemistry in Contrast-Enhanced Magnetic Resonance Imaging.
Abhishek Gupta, Peter Caravan, William S Price, Carlos Platas-Iglesias, Eric M Gale. Inorg Chem 2020
25
42

Binding and Release of FeIII Complexes from Glucan Particles for the Delivery of T1 MRI Contrast Agents.
Akanksha Patel, Didar Asik, Eric M Snyder, Alexandra E Dilillo, Paul J Cullen, Janet R Morrow. ChemMedChem 2020
10
42

A class of water-soluble Fe(III) coordination complexes as T1-weighted MRI contrast agents.
Run Wang, Lu An, Jing He, Mengmeng Li, Jingjing Jiao, Shiping Yang. J Mater Chem B 2021
4
75


Mn(II) compounds as an alternative to Gd-based MRI probes.
Mauro Botta, Fabio Carniato, David Esteban-Gómez, Carlos Platas-Iglesias, Lorenzo Tei. Future Med Chem 2019
33
42


Structure and Function of Iron-Loaded Synthetic Melanin.
Yiwen Li, Yijun Xie, Zhao Wang, Nanzhi Zang, Fabio Carniato, Yuran Huang, Christopher M Andolina, Lucas R Parent, Treffly B Ditri, Eric D Walter,[...]. ACS Nano 2016
63
28

Nano-sized and other improved reporters for magnetic resonance imaging of angiogenesis.
Simonetta Geninatti Crich, Enzo Terreno, Silvio Aime. Adv Drug Deliv Rev 2017
15
28

Bioresponsive, cell-penetrating, and multimeric MR contrast agents.
Jody L Major, Thomas J Meade. Acc Chem Res 2009
194
28

Smart dual T1 MRI-optical imaging agent based on a rhodamine appended Fe(III)-catecholate complex.
Duraiyarasu Maheshwaran, Thavasilingam Nagendraraj, T Sekar Balaji, Ganesan Kumaresan, S Senthil Kumaran, Ramasamy Mayilmurugan. Dalton Trans 2020
5
40

The interaction of MS-325 with human serum albumin and its effect on proton relaxation rates.
Peter Caravan, Normand J Cloutier, Matthew T Greenfield, Sarah A McDermid, Stephen U Dunham, Jeff W M Bulte, John C Amedio, Richard J Looby, Ronald M Supkowski, William DeW Horrocks,[...]. J Am Chem Soc 2002
297
28

Nephrogenic systemic fibrosis: suspected causative role of gadodiamide used for contrast-enhanced magnetic resonance imaging.
Peter Marckmann, Lone Skov, Kristian Rossen, Anders Dupont, Mette Brimnes Damholt, James Goya Heaf, Henrik S Thomsen. J Am Soc Nephrol 2006
921
28

Gd-AAZTA-MADEC, an improved blood pool agent for DCE-MRI studies on mice on 1 T scanners.
Dario Livio Longo, Francesca Arena, Lorena Consolino, Paolo Minazzi, Simonetta Geninatti-Crich, Giovanni Battista Giovenzana, Silvio Aime. Biomaterials 2016
25
28

Synthesis of two 3,5-disubstituted sulfonamide catechol ligands and evaluation of their iron(III) complexes for use as MRI contrast agents.
Daniel D Schwert, Nicholas Richardson, Gongjun Ji, Bernd Radüchel, Wolfgang Ebert, Peter E Heffner, Rick Keck, Julian A Davies. J Med Chem 2005
18
28

Influence of molecular parameters and increasing magnetic field strength on relaxivity of gadolinium- and manganese-based T1 contrast agents.
Peter Caravan, Christian T Farrar, Luca Frullano, Ritika Uppal. Contrast Media Mol Imaging 2009
292
28



Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.
Hyuna Sung, Jacques Ferlay, Rebecca L Siegel, Mathieu Laversanne, Isabelle Soerjomataram, Ahmedin Jemal, Freddie Bray. CA Cancer J Clin 2021
28

Organelle-targeted photothermal agents for cancer therapy.
Eunbin Hwang, Hyo Sung Jung. Chem Commun (Camb) 2021
5
40

Mitochondria-Targeted Triphenylphosphonium-Based Compounds: Syntheses, Mechanisms of Action, and Therapeutic and Diagnostic Applications.
Jacek Zielonka, Joy Joseph, Adam Sikora, Micael Hardy, Olivier Ouari, Jeannette Vasquez-Vivar, Gang Cheng, Marcos Lopez, Balaraman Kalyanaraman. Chem Rev 2017
543
28

Multifunctional nanoparticles for multimodal imaging and theragnosis.
Dong-Eun Lee, Heebeom Koo, In-Cheol Sun, Ju Hee Ryu, Kwangmeyung Kim, Ick Chan Kwon. Chem Soc Rev 2012
758
28

Boosting Cancer Therapy with Organelle-Targeted Nanomaterials.
Peng Gao, Wei Pan, Na Li, Bo Tang. ACS Appl Mater Interfaces 2019
92
28

Precise design strategies of nanomedicine for improving cancer therapeutic efficacy using subcellular targeting.
Xianglei Fu, Yanbin Shi, Tongtong Qi, Shengnan Qiu, Yi Huang, Xiaogang Zhao, Qifeng Sun, Guimei Lin. Signal Transduct Target Ther 2020
27
28

Hetero-Trifunctional Malonate-Based Nanotheranostic System for Targeted Breast Cancer Therapy.
Tapan Kumar Dash, Diptendu Patra, Parvathy Venu, Biswajit Das, Rangeet Bhattacharyya, Raja Shunmugam. ACS Appl Bio Mater 2021
3
66

Mitochondrially targeted anti-cancer agents.
Lucia Biasutto, Lan-Feng Dong, Mario Zoratti, Jiri Neuzil. Mitochondrion 2010
94
28

Drug delivery to mitochondria: the key to mitochondrial medicine.
M P Murphy, R A Smith. Adv Drug Deliv Rev 2000
316
28

Intracranial Gadolinium Deposition after Contrast-enhanced MR Imaging.
Robert J McDonald, Jennifer S McDonald, David F Kallmes, Mark E Jentoft, David L Murray, Kent R Thielen, Eric E Williamson, Laurence J Eckel. Radiology 2015
854
28


Mitochondria as a pharmacological target.
Adam Szewczyk, Lech Wojtczak. Pharmacol Rev 2002
369
28

Cancer nanomedicine: progress, challenges and opportunities.
Jinjun Shi, Philip W Kantoff, Richard Wooster, Omid C Farokhzad. Nat Rev Cancer 2017
28

Iron(III) Coordinated Polymeric Nanomaterial: A Next-Generation Theranostic Agent for High-Resolution T1-Weighted Magnetic Resonance Imaging and Anticancer Drug Delivery.
Diptendu Patra, Saikat Mukherjee, Ipsita Chakraborty, Tapan K Dash, Shantibhusan Senapati, Rangeet Bhattacharyya, Raja Shunmugam. ACS Biomater Sci Eng 2018
8
28

Cancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biology.
Nicolas Bertrand, Jun Wu, Xiaoyang Xu, Nazila Kamaly, Omid C Farokhzad. Adv Drug Deliv Rev 2014
28

Mitochondrial dysfunction in cancer.
Josephine S Modica-Napolitano, Keshav K Singh. Mitochondrion 2004
228
28

Mitochondria in cancer cells: what is so special about them?
Vladimir Gogvadze, Sten Orrenius, Boris Zhivotovsky. Trends Cell Biol 2008
442
28

Nephrogenic systemic fibrosis: incidence, associations, and effect of risk factor assessment--report of 33 cases.
Javier Perez-Rodriguez, Shenghan Lai, Benjamin D Ehst, Derek M Fine, David A Bluemke. Radiology 2009
150
28

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
Freddie Bray, Jacques Ferlay, Isabelle Soerjomataram, Rebecca L Siegel, Lindsey A Torre, Ahmedin Jemal. CA Cancer J Clin 2018
28

MRI for breast cancer screening, diagnosis, and treatment.
Monica Morrow, Janet Waters, Elizabeth Morris. Lancet 2011
192
28


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.